ProductNum | picture | CAS No. | Name and description | Size | Formula | Quick order |
---|---|---|---|---|---|---|
GC19173-50mg |
|
1496581-76-0 |
GNE-3511
|
0 | C23H26F2N6O | |
GC19173-10mg |
|
1496581-76-0 |
GNE-3511
|
0 | C23H26F2N6O | |
GC19173-5mg |
|
1496581-76-0 |
GNE-3511
|
0 | C23H26F2N6O | |
GC19173-1mg |
|
1496581-76-0 |
GNE-3511
|
0 | C23H26F2N6O | |
GC19171-50mg |
|
311795-38-7 |
Glutaminase C-IN-1
|
0 | C27H27BrN2O | |
GC19171-10mg |
|
311795-38-7 |
Glutaminase C-IN-1
|
0 | C27H27BrN2O | |
GC19171-5mg |
|
311795-38-7 |
Glutaminase C-IN-1
|
0 | C27H27BrN2O | |
GC19170-100mg |
|
1393124-08-7 |
Glucagon receptor antagonists-4
|
0 | C26H28F3N3O4 | |
GC19170-50mg |
|
1393124-08-7 |
Glucagon receptor antagonists-4
|
0 | C26H28F3N3O4 | |
GC19170-10mg |
|
1393124-08-7 |
Glucagon receptor antagonists-4
|
0 | C26H28F3N3O4 | |
GC19170-5mg |
|
1393124-08-7 |
Glucagon receptor antagonists-4
|
0 | C26H28F3N3O4 | |
GC19170-1mg |
|
1393124-08-7 |
Glucagon receptor antagonists-4
|
0 | C26H28F3N3O4 | |
GC19169-100mg |
|
1654725-02-6 |
GLPG1837
|
0 | C16H20N4O3S | |
GC19169-50mg |
|
1654725-02-6 |
GLPG1837
|
0 | C16H20N4O3S | |
GC19169-10mg |
|
1654725-02-6 |
GLPG1837
|
0 | C16H20N4O3S | |
GC19169-5mg |
|
1654725-02-6 |
GLPG1837
|
0 | C16H20N4O3S | |
GC19169-1mg |
|
1654725-02-6 |
GLPG1837
|
0 | C16H20N4O3S | |
GC19168-100mg |
|
1628260-79-6 |
GLPG1690
|
0 | C30H33FN8O2S | |
GC19168-50mg |
|
1628260-79-6 |
GLPG1690
|
0 | C30H33FN8O2S | |
GC19168-25mg |
|
1628260-79-6 |
GLPG1690
|
0 | C30H33FN8O2S | |